title: Evaluation of recurrent thrombosis and hypercoagulability.
abstract: The primary mechanisms for coagulation were described more than a century ago. However, inherited disorders of coagulation have been recognized for only a few decades. Activated protein C resistance and other related protein defects account for many cases of hypercoagulability. Primary care physicians can initiate testing in individuals for whom there is a high degree of suspicion. Testing for specific disorders is best performed before initiation of anticoagulant therapy. Management often includes long-term warfarin therapy following initial anticoagulation with heparin.
authors.affiliation: Baptist Regional Cancer Center, Jacksonville, Florida, USA.
authors.forename: J M
authors.initials: JM
authors.lastname: Harris
authors.forename: N
authors.initials: N
authors.lastname: Abramson
mesh_terms: D006801:Humans; D012008:Recurrence; D013927:Thrombosis / Q000209:etiology* / Q000235:genetics / Q000503:physiopathology / Q000628:therapy